CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS

The present invention relates a pharmaceutical composition comprising a controlled-release CNP agonist which reduces CNP agonist-associated side-effects, the use of such controlled-release CNP agonist and to methods of treatment. La présente invention concerne une composition pharmaceutique comprena...

Full description

Saved in:
Bibliographic Details
Main Authors RAU, HARALD, HERSEL, ULRICH, CLEEMANN, FELIX, SPROGOE, KENNETT, RASMUSSEN, CAROLINE ELISABETH
Format Patent
LanguageEnglish
French
Published 02.01.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates a pharmaceutical composition comprising a controlled-release CNP agonist which reduces CNP agonist-associated side-effects, the use of such controlled-release CNP agonist and to methods of treatment. La présente invention concerne une composition pharmaceutique comprenant un agoniste de CNP à libération contrôlée qui réduit les effets secondaires associés aux agonistes de CNP, ainsi que l'utilisation d'un tel agoniste de CNP à libération contrôlée et des procédés de traitement.
Bibliography:Application Number: CA20173008017